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SUMMARY
The aim of this case series was to describe the clinical, laboratory and epidemiological characteristics and the presentation of
bacillary angiomatosis cases (and/or parenchymal bacillary peliosis) that were identified in five public hospitals of Rio de Janeiro
state between 1990 and 1997; these cases were compared with those previously described in the medical literature.
Thirteen case-patients were enrolled in the study; the median age was 39 years and all patients were male. All patients were
human immunodeficiency virus type 1 (HIV-1) infected and they had previous or concomitant HIV-associated opportunistic infections
or malignancies diagnosed at the time bacillary angiomatosis was diagnosed. Median T4 helper lymphocyte counts of patients was 96
cells per mm3. Cutaneous involvement was the most common clinical manifestation of bacillary angiomatosis in this study. Clinical
remission following appropriate treatment was more common in our case series than that reported in the medical literature, while the
incidence of relapse was similar. The frequency of bacillary angiomatosis in HIV patients calculated from two of the hospitals
included in our study was 1.42 cases per 1000 patients, similar to the frequencies reported in the medical literature. Bacillary angiomatosis
is an unusual opportunistic pathogen in our setting.
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INTRODUCTION
Bacillary angiomatosis is a relatively uncommon emergent infectious
disease, caused by two species of Gram negative bacilli: Bartonella
(Rochalimaea) henselae and Bartonella (Rochalimaea) quintana11. It
was first described in Human Immunodeficiency Virus (HIV) infected
patient who presented with painless hardened subcutaneous nodules and
fever22. The name bacillary angiomatosis came from the vascular
proliferation described on histologic examination of clinical specimens
(skin, lymph nodes, bone, etc) and from the bacilli identified on Warthin-
Starry silver stain9. Skin and regional lymph nodes involvement are more
frequently described11 but bacillary angiomatosis may affects a variety
of internal organs including: liver, spleen, bone, oral mucosa,
gastrointestinal tract, lung and brain5,7,8,15,26. It also occurs in other
immunocompromised hosts, with similar clinical presentation,8,17,20 and
a few cases have been reported in immunocompetent host4,23.
In 1990, PERKOCHA et al.18 described a newly recognized clinical/
pathologic phenomenon in HIV infected patients: the bacillary peliosis
hepatis. Later, SLATER et al.21 suggested that a better description of
this pathologic phenomenon might be “parenchymal bacillary peliosis”
because of the finding of peliotic lesions in the spleen as well as in the
liver. These authors also related that only B. henselae was the etiologic
agent of bacillary angiomatosis and parenchymal bacillary peliosis.
While bacillary angiomatosis is a potentially fatal illness5, it may be
treated with relatively inexpensive and non-toxic antibiotics, if an early
diagnosis is made9. However, if diagnosed later it is more difficult to
treat, and often there is no clinical suspicion or appropriate diagnosis
made in a timely fashion, resulting in significant morbidity and mortality
in those who did not receive treatment25.
Thus, a better understanding of the clinical picture, optimal diagnostic
approach, and appropriate treatment for bacillary angiomatosis is
important to disseminate to physicians caring for AIDS patients; such
information will allow for better success in treatment and avoid future
cases of patients whose diagnosis only comes at the time of post mortem
histopathology examination.
In this case series of bacillary angiomatosis we describe the
demographics, clinical presentation, laboratory exams, and clinical course
of 13 patients diagnosed in five hospitals of metropolitan Rio de Janeiro
between 1990 to 1997, and contrast our findings with those found in the
current medical literature.
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PATIENTS AND METHODS
We conducted a retrospective review of hospital charts of 13 patients
with confirmed or suspected cases of bacillary angiomatosis and/or
peliosis hepatis admitted to five public institutions which are reference
centers for HIV/AIDS treatment in metropolitan Rio de Janeiro: Hospital
Universitário Clementino Fraga Filho/Universidade Federal do Rio de
Janeiro (HUCFF/UFRJ), Hospital Universitário Pedro Ernesto/
Universidade do Estado do Rio de Janeiro (HUPE/UERJ), Hospital
Universitário Antonio Pedro/Universidade Federal Fluminense (HUAP/
UFF), Hospital Evandro Chagas/Fundação Oswaldo Cruz (HEC/
FIOCRUZ) and Hospital dos Servidores do Estado (HSE), between 1990
to 1997.
A standard form was completed on all patients, based on physician
review of the hospital medical record and the histopathological report
taken from biopsy, and demographics data, clinical presentation,
laboratory examination results, and treatment and clinical outcome
recorded.
Definitions:
A confirmed bacillary angiomatosis case was defined by the
following histopathologic criteria: a) a lobular proliferation of small,
round blood vessels with plump endothelial cells (with or without
cytologic atypia) protruding into the vascular lumen; b) necrosis present
within the centers of vascular lobules; c) a mixed inflammatory cell
infiltrate with neutrophils and leukocytoclasis; d) granular amphophilic
interstitial material revealing bacilli on silver staining (e.g. Warthin –
Starry) or electron microscopy or both12.
A probable case of bacillary angiomatosis was defined as a patient
whose histhologic exam showed all criteria above described with the
exception of criteria d.
Parenchymal lesions of bacillary peliosis revealed: a) dilated
capillaries or multiple dilated, blood filled spaces and b) a myxoid stroma
containing a mixture of inflammatory cells and clumps of granular
amphophilic material (revealing bacilli on silver staining or electron
microscopy) or both18.
An AIDS case was made according to the definition for adults and
adolescents of Centers for Disease Control and Prevention (CDC)2; and
stage of HIV infection was made using the revised CDC classification
system, 1993. Mode of transmission of HIV was determined to be
“unknown” if appropriate investigation revealed no definitive
information1.
Duration time from disease onset until the first medical
evaluation was defined by the time period between the beginning of
signs and symptoms related to bacillary angiomatosis and first medical
evaluation.
Specific treatment was defined as the receipt of a macrolide
(primarily erythromycin) antibiotic or tetracycline by the patient.
Clinical course was characterized in the following manner: a)
remission: was the absence of all clinical signs and symptoms related to
bacillary angiomatosis following appropriate treatment; b) clinical
improvement: was defined as partial resolution of specific signs and
symptoms following appropriate treatment, c) clinical deterioration:
progressive deterioration of clinical picture resulting in death without
specific treatment; d) relapse: reappearance of signs and symptoms
related to bacillary angiomatosis following remission; e) therapeutic
failure was defined as the absence of remission following appropriate
treatment or the appearance of new signs and symptoms during
appropriate treatment.
For those patients who died from a cause probably not related to
bacillary angiomatosis, the survival period after diagnosis was considered;
the occurrence of death was considered as unknown if a time period
greater than six months had lapsed between the last registered patient
visit in the hospital records and the review performed by one of the
authors.
Statistical analysis: Data collected and frequency distribution were
calculated using computer Program EPI-INFO, version 6,0, 1994, CDC,
Atlanta, Georgia, United States.
RESULTS
Eleven patients with a confirmed diagnosis of bacillary angiomatosis
(one also with peliosis hepatitis) and two with a probable diagnosis (one
with isolated bone lesion and another with mucosae involvement) are
included in this analysis: seven patients were from HUCFF/UFRJ, two
from HUPE/UERJ, two from HUAP/UFF, one from HEC/FIOCRUZ
and other from HSE. If we consider as numerator the number of cases of
bacillary angiomatosis diagnosed at HUCFF and in HSE, between 1992
to 1997, and using as denominator the number of all AIDS cases notified
in these hospitals during the same time period, the frequency of bacillary
angiomatosis was 1.42 cases per 1000 patients.
Socio-demographics and epidemiological data are summarized in
Table 1.
Table 1
Demographic and epidemiological characteristics of patients with bacillary
angiomatosis
Characteristics Patients (n=13)
Age, mean; median (range)
(years) 38.5 ± 7.6; 39 (27 to 56)
Sex, % male 100
Race, % white 76.9 (10/13)
Residence, % from Rio de Janeiro 84.6 (11/13)
Monthly family income, mean;
median (MI)* 5.2 ± 0.8; 5 (4.5 to 6)
HIV infection (%) 100
Homosexual (%) 53.8 (7/13)
Heterosexual (%) 38.5 (5/13)
History of cat trauma (%) 25 (1/4)
Alcohol intake (%) 27.3 (3/11)
*minimal income = 70 US $
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Table 2
Frequency of opportunistic infections and/or neoplasms found in association
with diagnosis of bacillary angiomatosis
Opportunistic infections and/or
neoplasms related to HIV* Frequency
Oral candidiasis 76.92% (10/13)
Esophageal candidiasis 30.76% (4/13)
Pneumocystis carinii pneumonia 15.38% (2/13)
Kaposi’s sarcoma 15.38% (2/13)
Cerebral toxoplasmosis 15.38% (2/13)
Cytomegalovirus 7.69% (1/13)
Hodgkins lymphoma 7.69% (1/13)
*Each patient may have presented with one or more opportunistic infections or
neoplasm prior to or concomitant with diagnosis of bacillary angiomatosis.
Table 3
Frequency of signs and symptoms in 13 patients with bacillary angiomatosis
Signs and/or symptoms Frequency
Fever 84.6% (11/13)
Skin lesions 76.9% (10/13)
Weight loss 69.2% (9/13)
Anorexia 61.5% (8/13)
Hepatomegaly 61.5% (8/13)
Lymphadenopathy 53.8% (7/13)
Diarrhea 53.8% (7/13)
Malaise 46.2% (6/13)
Nausea or vomiting 38.5% (5/13)
Splenomegaly 23.1% (3/13)
Bone pain 15.4% (2/13)
Night sweats 15.4% (2/13)
Enlargement of  soft tissues 15.4% (2/13)
Fig. 1 - Osteolytic lesions due to bacillary angiomatosis. Fig. 2 - Skin (Warthin-Starry X 1000) – Presence of clusters of silver staining bacilli.
The patients included in this case series often presented with
concomitant opportunistic infections and/or neoplasm associated with
HIV at the time of the bacillary angiomatosis diagnosis. Ten of 13 patients
(76.9%) had C category classification according to CDC and 23.1% (3/
13) category B. Eight of 13 patients (61.5%) received antiretroviral
therapy and 69.2% (9/13) prophylaxis for Pneumocystis carinii with
trimethoprim-sulfamethoxazole (TMP-SMX). No patients received
prophylaxis for atypical mycobacteria. The frequency and type of
opportunistic infections and/or neoplasm associated to HIV are presented
in Table 2.
Laboratory results of patients with bacillary angiomatosis showed
that the mean and median CD4+ T cell count were 85.8 cells/mm3 ± 73.9
and 96 cells/mm3 respectively, the mean and median alkaline phosphatase
were 580.87 U.I./L ± 630.34 and 395.5 U.I./L respectively while the
mean and median aspartate aminotransferase were 78.54 U.I./L ± 73.70
and 46 U.I./L respectively. All patients were anaemic and the mean and
median hematocrit were 24.4% ± 6.2 and 26% respectively.
Ten of 13 patients (76.9%) presented with skin or subcutaneous lesions,
and one of these also had intestinal, splenic, and pancreatic involvement
with concomitant parenchymal bacillary peliosis identified at autopsy.
Three patients had no skin or subcutaneous lesions: one had bone
involvement (Fig. 1); one had an inflammatory soft tissue tumour; and
one had mucosal involvement of the tongue. The clinical picture of patients
with bacillary angiomatosis in this study is presented in Table 3.
The median duration time from disease onset until the first medical
evaluation was 30 days, with mean of 50.77 ± 41.08 days and range of
14 to 120 days. The median time between the first medical consultation
for this problem and the diagnosis of bacillary angiomatosis was 94
days, with mean of 128.92 ± 100.60 days and range of 23 to 300 days.
The histopathologic diagnoses (Fig. 2) were performed prior to death in
69.2% of cases (9/13) and in 30.8% (4/13), after death.
Appropriate treatment was initiated in 76.9% (10/13) of patients, with
median duration of treatment of eight weeks, mean of 8.7 ± 3.2 weeks,
and range of two to 12 weeks. Of these ten patients who received treatment,
8 received erythromycin and one each received clarithromycin and
tetracycline. One patient received, following erythromycin, doxycycline
for two weeks due to gastrointestinal intolerance from erythromycin, and
subsequently received clarithromycin suppressive treatment.
GAZINEO, J.L.D.; TROPE, B.M.; MACEIRA, J.P.; MAY, S.B.; COELHO, J.M.C.O.; LAMBERT, J.S. & NOGUEIRA, S.A. - Bacillary angiomatosis: description of 13 cases reported in five
reference centers for AIDS treatment in Rio de Janeiro, Brazil. Rev. Inst. Med. trop. S. Paulo, 43(1):1-6, 2001.
Seven of 13 patients went into remission (53.8%), three into clinical
improvement (23.1%) and three into clinical deterioration (23.1%). Of
ten patients who received appropriate treatment, seven went into
remission, and the frequency of therapeutic failure was 30% (3/10). In
addition, among those patients who had remissions, 20% (2/10) relapsed
and were re-treated with doxycycline and rifampin.
Eight of 13 patients went into death (61.5%), being 28.6% of them
(2/7) probably related to bacillary angiomatosis (in one patient the cause
of death was unknown). The median time of survival after the diagnosis
of bacillary angiomatosis was 10.5 months, mean of 10.75 ± 5.32 months
and range of five to 17 months. Seven of 13 patients (53.8%) had
opportunistic infections after the diagnosis of bacillary angiomatosis.
DISCUSSION
Bacillary angiomatosis is an emergent infectious disease, and is
included in category B of the CDC revised system for classification of
HIV infection and surveillance for AIDS cases in adults and adolescents2.
However, as previously described by MOHLE-BOETANI et al.14 and
PLETTENBERG et al.19, the majority of patients with this infection
present with advanced stages of immunosuppression (CD4+ T cell count
less than 200 cells/mm3); some authors have suggested that bacillary
angiomatosis should be given a category C case definition14.
Bacillary angiomatosis and HIV is a relatively rare disease:
PLETTENBERG et al.19 described 21 cases from 22 AIDS reference
centers in Germany and found a frequency of 1.2 cases per 1,000 HIV
infected patients between 1990 to 1996. Our data gives a similar
frequency in incidence data reviewed from two hospitals in Rio de Janeiro
(1.42 cases per 1,000 patients). However, because of the retrospective
nature of our study, all cases of bacillary angiomatosis may not have
been included in this analysis; additionally, underreporting of AIDS cases
in our setting is common, which may affect our incidence data. Other
patients with bacillary angiomatosis, for example those who received
transplants8, those with neoplasms13, those receiving immunosuppressive
treatments17,20, and normal patients who had contact with cats4,23 as
described in medical literature were not identified in our study.
Concerning the sex distribution of the patients with bacillary
angiomatosis, all patients were men (Table 1), similar to the description
in the medical literature14,19. This likely represents the distribution of
HIV infection in the population, rather than a predilection for men over
women1. The median age (39 years) (Table 1) is identical to what was
described by PLETTENBERG et al.19 and slightly older than that reported
by MOHLE-BOETANI et al.14 (37 years) who performed a case-control
study. This age range likely reflects the age distribution of HIV infection
in the population studied.
In our case series of bacillary angiomatosis, trauma related to cat injury
was reported by 25% (1/4) of our patients whose medical records mentioned
contact with cats. This frequency is low when compared to other reports
in the medical literature10,24. Unfortunately this data was not collected
prospectively from our study, and contact with cats was not a routine
question obtained in most of our patients included in the analysis.
All patients included in this study had prior (or concomitant)
opportunistic infections (Table 2) suggesting they had more advanced
stages of HIV infection. This frequency of AIDS was lower to that
reported (94%) by MOHLE-BOETANI et al.14. In their study, patients
with bacillary angiomatosis had statistically more chance of having AIDS
when compared to controls (HIV infected patients without bacillary
angiomatosis). Eight of our patients (61.5%) used cotrimoxazole for P.
carinii prophylaxis (primary or secondary) possibly suggesting that TMP-
SMX does not provide protection against bacillary angiomatosis or
peliosis. KOEHLER et al.10 and MOHLE-BOETANI et al.14 made a
similar observation. None of our patients had received azithromycin or
clarithromycin for primary prophylaxis against atypical mycobacteria,
as it was not the standard of care at the time of the study, and has just
been recommended more recently3.
The median CD4+ T cell count was 96 cells/mm3, and none of these
patients had count above 200 cells/mm3, indicating a group with more
advanced immunosuppression; similarly to the studies of MOHLE-
BOETANI et al.14 and PLETTENBERG et al.19, where median CD4+ T
cell counts of 21 and 30 cells/mm3, respectively, were reported. The
median value of alkaline phosphatase was 395.5 U.I./L, higher than values
reported from the cases of KOEHLER et al.10 and MOHLE-BOETANI
et al.14 (190 and 192 U.I./L, respectively). In this study a statistical
association, in both univariate and multivariate analysis, was found between
bacillary angiomatosis and elevated alkaline phosphatase ( 153 U.I./L),
even after controlling for anaemia and CD4+ T cell count. Our patients
had a lower hematocrit (26%) when compared to other studies10,14.
Regarding the clinical picture of bacillary angiomatosis, MOHLE-
BOETANI et al.14 reported that the cases of bacillary angiomatosis were
more commonly associated with fever, anorexia, lymphadenopathy,
hepatomegaly, and splenomegaly when compared to controls; but
KOEHLER et al.10 reported that their cases of bacillary angiomatosis
were more likely than the controls (without bacillary angiomatosis) to
have poor appetite, weight loss and recurrent fevers in the last six months
preceding their diagnosis. In our cases, the most frequent signs and
symptoms were: fever, weight loss, anorexia, hepatomegaly and
lymphadenopathy (Table 3), similar to other descriptions in the
literature10,14, and these symptoms and signs disappeared after appropriate
treatment, suggesting they were related to bacillary angiomatosis and
not to other opportunistic infections which presented simultaneously in
some patients.
The median of duration time from disease onset until the first medical
evaluation was 30 days; similar to the findings in a case controlled study
performed by MOHLE-BOETANI et al.14 (28 days). However the median
time between the first consultation and the diagnosis of bacillary
angiomatosis was 94 days, which is three times longer than that reported
by MOHLE-BOETANI et al.14. This reflects the lack of suspicion of the
diagnosis of bacillary angiomatosis among the Brazilian caretakers and
a delay in obtaining a tissue biopsy to perform an appropriate
histopathologic exam.
Ten of 13 patients (76.9%) presented with skin and/or with
subcutaneous involvement, higher than that reported by MOHLE-
BOETANI et al.14 (55%) but lower than that reported by PLETTENBERG
et al.19 (90%). Osteolytic lesions were seen on bone X-ray of the two
patients who complained of bone pain. Thus, it is important to look for
bone lesions in all patients with bacillary angiomatosis with similar
complaints because treatment of bone lesions requires a longer duration
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of appropriate treatment than if only skin lesions were present, according
to KOEHLER & TAPPERO11.
The frequency of lymph node involvement in the study of MOHLE-
BOETANI et al.14 was 26%. In our present series of bacillary
angiomatosis, while admittedly not confirmed by histopathologic
findings, lymphadenopathy was present in 53.8% (7/13) of our patients
(Table 3).
Liver and spleen involvement in bacillary angiomatosis varied from
12% to 26%10,14. Nine of our patients (69.2%) presented with
hepatomegaly and/or splenomegaly but liver and spleen lesions suspected
secondary to bacillary angiomatosis were not confirmed by biopsy. One
patient who underwent autopsy had evidence of parenchymal bacillary
peliosis. This same patient also showed intestinal and pancreatic
involvement. Intestinal lesions of bacillary angiomatosis are
uncommon7,26,27. Our literature search found no mention of pancreatic
involvement in bacillary angiomatosis, which is likely very rare.
A specific etiologic diagnosis was not made in any of our patients as
there was no adequate system for microbiological identification (lysis-
centrifugation); and no laboratory facilities were available to demonstrate
the agent of bacillary angiomatosis by polymerase chain reaction,
immuno-histochemistry or serology in our hospitals. However all patients
described in this study did have the diagnosis of bacillary angiomatosis
made by histophatologic examination.
Among patients treated with appropriate antibiotics, a 70% (7/10)
frequency of remission was achieved, similar to that reported by
PLETTENBERG et al.19 (65%). Besides a therapeutic failure of 30% (3/
10) was found in our casuistry. The reasons for 30% non-response may
be related to inadequate absorption of drugs, inadequate adherence, an
inadequate course of therapy, a lack efficacy of the antibiotic16, or to
resistance of Bartonella spp to the antibiotics used6.
Two of 10 treated patients (20%) relapsed, similar to the frequency
reported by PLETTENBERG et al.19 (23.8%). The relapses may be due
to the absence of a bactericidal effect of the antibiotic16; to the possibility
of re-infection6, or to the possibility of co-infection by more than one
species of Bartonella, with one of them resistant to the antibiotic used6.
The two patients who relapsed subsequently had remission following
treatment with doxycicline and rifampin.
We conclude that bacillary angiomatosis is a relatively uncommon
infectious disease in our setting, an opportunistic disease in advanced
AIDS patients, where an earlier diagnosis can potentially lead to a better
outcome.
RESUMO
Angiomatose bacilar: descrição de 13 casos relatados em
cinco centros de referência para tratamento de AIDS
no Rio de Janeiro, Brasil.
Esta série de casos foi conduzida com o objetivo de descrever a
apresentação clínica, as características epidemiológicas, os exames
laboratoriais e a evolução dos casos de angiomatose bacilar (e/ou peliose
parenquimatosa bacilar) ocorridos em cinco hospitais públicos do Rio
de Janeiro, no período de 1990 a 1997, comparando a casuística
encontrada com a relatada na literatura médica.
Foram incluídos 13 pacientes com mediana de idade de 39 anos,
sendo todos pertencentes ao sexo masculino. Todos os pacientes
apresentaram infecções oportunistas e/ou neoplasias associadas ao vírus
da imunodeficiência humana (HIV-1) anteriores (ou concomitantes) ao
diagnóstico de angiomatose bacilar. A mediana da contagem de linfócitos
T Helper encontrada foi de 96 células por mm3. O acometimento cutâneo
foi a apresentação clínica de angiomatose bacilar mais freqüente deste
estudo. A freqüência de remissão após tratamento específico foi
discretamente maior do que a relatada na literatura médica, enquanto a
de recidiva foi semelhante. A freqüência de angiomatose bacilar entre
indivíduos infectados pelo HIV de dois hospitais do Rio de Janeiro foi
de 1,42 casos por 1.000 pacientes, semelhante ao relatado na literatura
médica e sugestivo de que a angiomatose bacilar é relativamente incomum
em nosso meio.
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